Clinical trial
The Safety and Tolerability of GW805858 in Healthy Volunteers and Mild…
NCT00453791 · GlaxoSmithKline, Industry · Terminated
Key facts
| NCT number | NCT00453791 |
|---|---|
| Title | The Safety and Tolerability of GW805858 in Healthy Volunteers and Mild Asthmatics |
| Official title | A Randomised, Single and Repeat Dose, Double-blind, Placebo Controlled Study to Assess the Safety and Tolerability of GW805858 in Healthy Volunteers and Mild Asthmatics |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | GW805858, Placebo |
| Enrollment | 31 |
| Start date | Feb 7, 2006 |
| Primary completion | Apr 10, 2006 |
| Completion | Apr 10, 2006 |
| First posted | Mar 29, 2007 |
| Last update posted | Sep 29, 2017 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: